| 19.99 0.09 (0.45%) | 06-18 10:26 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23.59 |
1-year : | 27.55 |
| Resists | First : | 20.2 |
Second : | 23.59 |
| Pivot price | 19.33 |
|||
| Supports | First : | 19.22 |
Second : | 18.62 |
| MAs | MA(5) : | 19.66 |
MA(20) : | 19.37 |
| MA(100) : | 18.62 |
MA(250) : | 17.13 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 82.6 |
D(3) : | 73.1 |
| RSI | RSI(14): 62.5 |
|||
| 52-week | High : | 20.2 | Low : | 13.32 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ HQH ] has closed below upper band by 9.2%. Bollinger Bands are 16.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 20 - 20.06 | 20.06 - 20.13 |
| Low: | 19.55 - 19.62 | 19.62 - 19.7 |
| Close: | 19.77 - 19.88 | 19.88 - 20 |
Abrdn Healthcare Investors is a closed-end equity fund, stewarded by abrdn Inc. Its mandate involves global public equity investments, specifically targeting the healthcare sector, encompassing businesses in biotechnology, medical devices, and pharmaceuticals. The primary focus is on high-growth, small-capitalization companies. The portfolio is constructed using a fundamental analysis approach, scrutinizing companies based on their current or projected market position for products and services, the experience of their management teams, their technological prowess, and their capability to either self-fund growth or secure external financing. Its performance is measured against several benchmarks: the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Established on October 31, 1986, the fund is domiciled in the United States.
Thu, 11 Jun 2026
Mahai Chris LaVictoire joins abrdn Healthcare (HQH) as reporting insider - Stock Titan
Mon, 08 Jun 2026
Abrdn Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
Wed, 20 May 2026
HQH: Growth Potential Limited But Portfolio Structure (NYSE:HQH) - Seeking Alpha
Fri, 15 May 2026
Abrdn Healthcare Investors Q1 2026 Commentary (NYSE:HQH) - Seeking Alpha
Mon, 11 May 2026
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - PR Newswire
Fri, 01 May 2026
5 Best Closed-End Funds for 2026 | Investing - U.S. News - Money
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 57 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 142 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 4 % |
| Operating Margin | 561.3 % |
| Return on Assets (ttm) | -125.5 % |
| Return on Equity (ttm) | -0.4 % |
| Qtrly Rev. Growth | 5.54e+006 % |
| Gross Profit (p.s.) | -55.4 |
| Sales Per Share | 31.85 |
| EBITDA (p.s.) | 7.28947e+006 |
| Qtrly Earnings Growth | 4.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.62 |
| Price to Cash Flow | 0.77 |
| Dividend | 0 |
| Forward Dividend | 131600 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|